London Co. of Virginia Has $26.56 Million Holdings in Ingevity Corporation $NGVT

London Co. of Virginia cut its holdings in shares of Ingevity Corporation (NYSE:NGVT) by 4.4% during the fourth quarter, HoldingsChannel.com reports. The firm owned 448,770 shares of the company’s stock after selling 20,708 shares during the quarter. London Co. of Virginia’s holdings in Ingevity were worth $26,558,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in NGVT. Global Retirement Partners LLC acquired a new position in Ingevity during the 4th quarter valued at about $27,000. Meeder Asset Management Inc. acquired a new position in Ingevity during the 4th quarter valued at about $33,000. Geneos Wealth Management Inc. lifted its position in Ingevity by 85.8% during the 2nd quarter. Geneos Wealth Management Inc. now owns 838 shares of the company’s stock valued at $36,000 after purchasing an additional 387 shares during the period. Headlands Technologies LLC acquired a new position in Ingevity during the 2nd quarter valued at about $46,000. Finally, Kestra Advisory Services LLC acquired a new position in Ingevity during the 4th quarter valued at about $47,000. 91.59% of the stock is currently owned by institutional investors and hedge funds.

Ingevity Stock Performance

Shares of NYSE:NGVT opened at $71.64 on Wednesday. The company has a market capitalization of $2.49 billion, a price-to-earnings ratio of -20.18 and a beta of 1.18. The firm’s 50 day simple moving average is $71.42 and its 200 day simple moving average is $67.47. The company has a debt-to-equity ratio of 27.83, a current ratio of 1.42 and a quick ratio of 0.92. Ingevity Corporation has a fifty-two week low of $39.74 and a fifty-two week high of $79.29.

Ingevity (NYSE:NGVT) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $1.15 earnings per share for the quarter, beating analysts’ consensus estimates of $0.84 by $0.31. The business had revenue of $258.00 million for the quarter, compared to the consensus estimate of $254.73 million. Ingevity had a negative net margin of 10.55% and a positive return on equity of 207.82%. Ingevity’s revenue for the quarter was up 4.1% on a year-over-year basis. During the same period last year, the company posted $1.01 EPS. Ingevity has set its FY 2026 guidance at 4.700-5.200 EPS. As a group, sell-side analysts forecast that Ingevity Corporation will post 5.05 earnings per share for the current year.

Analysts Set New Price Targets

NGVT has been the topic of a number of research reports. Wells Fargo & Company upped their target price on shares of Ingevity from $65.00 to $75.00 and gave the company an “equal weight” rating in a research report on Friday, February 27th. BMO Capital Markets restated an “outperform” rating and set a $83.00 target price on shares of Ingevity in a research report on Monday, March 2nd. Jefferies Financial Group restated a “buy” rating and set a $82.00 target price on shares of Ingevity in a research report on Thursday, February 26th. Wall Street Zen downgraded shares of Ingevity from a “strong-buy” rating to a “buy” rating in a research report on Saturday. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Ingevity in a research report on Tuesday, April 21st. Two investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $80.00.

Insiders Place Their Bets

In other Ingevity news, SVP Terrance M. Dyer sold 496 shares of Ingevity stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $68.49, for a total transaction of $33,971.04. Following the transaction, the senior vice president directly owned 7,202 shares in the company, valued at approximately $493,264.98. The trade was a 6.44% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 0.88% of the company’s stock.

Ingevity Profile

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.